Latifa Zekri

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Benign Prostatic Hyperplasia

Pluripotent Stem Cells

Top Venues

Science translational medicine

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sylwia Anna Stefańczyk, Clara Hayn, Jonas Heitmann, Susanne Jung, Latifa Zekri, Melanie Märklin
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia. Cancers 16 (13) (2024)
Sylwia Anna Stefańczyk, Clara Hayn, Jonas Heitmann, Susanne Jung, Latifa Zekri, Melanie Märklin
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia. Cancers 16 (13) (2024)
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, Boris Klimovich, Mary Christie, Cornelia Lindner, Sofie Kämereit, Nisha Prakash, Stefanie Müller, Sophie Stotz, Andreas Maurer, Carsten L Greve, Bastian Schmied, Daniel Atar, Hans-Georg Rammensee, Gundram Jung, Helmut R Salih
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies. Science translational medicine 16 (737) (2024)
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, Boris Klimovich, Mary Christie, Cornelia Lindner, Sofie Kämereit, Nisha Prakash, Stefanie Müller, Sophie Stotz, Andreas Maurer, Carsten L Greve, Bastian Schmied, Daniel Atar, Hans-Georg Rammensee, Gundram Jung, Helmut R Salih
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies. Science translational medicine 16 (737) (2024)
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, Boris Klimovich, Mary Christie, Cornelia Lindner, Sofie Kämereit, Nisha Prakash, Stefanie Müller, Sophie Stotz, Andreas Maurer, Carsten L Greve, Bastian Schmied, Daniel Atar, Hans-Georg Rammensee, Gundram Jung, Helmut R Salih
Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies. Science translational medicine 16 (737) (2024)
Sebastian Hörner, Moustafa Moustafa-Oglou, Karin Teppert, Ilona Hagelstein, Joseph Kauer, Martin Pflügler, Kristina Neumann, Hans-Georg Rammensee, Thomas M Metz, Andreas Herrmann, Helmut R Salih, Gundram Jung, Latifa Zekri
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases. Cancers 14 (16) (2022)
Joseph Kauer, Fabian Vogt, Ilona Hagelstein, Sebastian Hörner, Melanie Märklin, Stefanie Maurer, Helmut R Salih, Gundram Jung, Latifa Zekri
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies. Cancers 13 (18) (2021)
Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans-Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih, Gundram Jung
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer. EMBO molecular medicine 13 (2) (2020)